Claro Advisors’s BlackRock Health Sciences Trust BME Stock Holding History
Bought
Maintained
Sold
Other funds holding BME
NRW
Claro Advisors's BME Position: Q2 2022 in Review
Claro Advisors sold out of BlackRock Health Sciences Trust (BME) in Q2 2022, closing a stake of 8,725 shares — an estimated $221K sold.
Claro Advisors first reported a position in BME in Q1 2022 and held it in 1 quarter. The position peaked at $221K in Q1 2022. 62 funds tracked by Wall St. Rank hold BME as of Q2 2022.
- Claro Advisors reported no remaining BlackRock Health Sciences Trust position as of Q2 2022 after selling out during the quarter.
- Claro Advisors sold 8,725 BlackRock Health Sciences Trust shares in Q2 2022, an estimated $221K.
- Claro Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2022 and held it in 1 quarter.
- Claro Advisors's BlackRock Health Sciences Trust position peaked at $221K in Q1 2022.
- 62 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q2 2022.
Based on Claro Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.